Get the Stockscreener App
2.25
2.17%
-0.05
Ispecimen Inc stock is traded at $2.25, with a volume of 37,953.
It is down -2.17% in the last 24 hours and down -5.86% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$2.30
Open:
$2.3624
24h Volume:
37,953
Relative Volume:
0.30
Market Cap:
$3.23M
Revenue:
$1.03M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.034
EPS:
-66.0832
Net Cash Flow:
$-8.21M
1W Performance:
+1.35%
1M Performance:
-5.86%
6M Performance:
-81.44%
1Y Performance:
-95.18%
1-Day Range:
$2.24
$2.3624
1-Week Range:
$2.18
$2.38
52-Week Range:
$1.77
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.25 | 3.26M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen Pays $2 Million for Three-Month Marketing Agreement - Minichart
iSpecimen Engages IR Agency for Investor Marketing - TipRanks
iSpecimen (ISPC) revenue drops to $308K as losses deepen and cash burns - Stock Titan
iSpecimen settles arbitration with WestPark Capital for $97,500, ends agreements - Investing.com South Africa
Form 8K iSpecimen Inc For: 11 August By Investing.com - Investing.com Nigeria
IspecimenEnters Settlement Agreement With Westpark Capital On August 6, 2026 - TradingView
iSpecimen Settles Arbitration and Terminates WestPark Agreements - TipRanks
E.F. Hutton & Co. Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen - The Manila Times
E.F. Hutton serves as placement agent for iSpecimen $5M offering By Investing.com - Investing.com India
iSpecimen Inc. Prices $5 Million Public Offering of Common Stock and Pre-Funded Warrants to Fuel Growth and Innovation – Minichart - Minichart
iSpecimen Inc (ISPC) Stock News Today - TradingKey
E.F. Hutton serves as agent for iSpecimen $5M offering By Investing.com - Investing.com India
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
E.F. Hutton serves as placement agent for iSpecimen $5M offering - Investing.com Nigeria
iSpecimen Completes $5 Million Public Offering - TipRanks
ISpecimen Closes $5 Million Public Offering of Common Stock, Warrants - marketscreener.com
iSpecimen Inc. Closes $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded ... - Caledonian Record
E.F. Hutton serves as agent for iSpecimen $5M offering - Investing.com
iSpecimen prices $5M public offering at $1.30 per share By Investing.com - Investing.com India
iSpecimen prices $5M public offering at $1.30 per share - Investing.com
ISpecimen Inc. Announces Pricing of $5 Millio - Moomoo
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Yahoo Finance
iSpecimen Inc. SEC Filing (Jul 31, 2026) - Stock Titan
iSpecimen Company Profile & Introduction - Moomoo
iSpecimen Inc. Revenue Breakdown – NASDAQ:ISPC - TradingView
iSpecimen (ISPC) Q3 2024 Earnings: EPS Misses by Over 980% Amid No Reported RevenueEarnings Beat Streak - dars.gov.et
iSpecimen Inc (ISPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ISPC|iSpecimen Inc|Price:2.280|Chg%:+0.040 - tradingkey.com
iSpecimen Inc (ISPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iSpecimen Inc (ISPC) Cash Flow - TradingKey
iSpecimen Inc (ISPC) Balance Sheet - TradingKey
ISPC|iSpecimen Inc|Price:1.970|Chg%:-0.260 - TradingKey
iSpecimen Inc (ISPC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
What's Driving iSpecimen's Recent Stock Surge - Kavout | AI
TradingKey - TradingKey
iSpecimen (ISPC) Shares Slide 11.7% as Stock Tests Key Support Near $1.87Island Reversal - dars.gov.et
iSpecimen Inc (ISPC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ISPC stock holds the spotlight as iSpecimen builds around Q1 2026 - Ad-hoc-news.de
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Massive EPS Miss and Revenue Absence Deepen Investor ConcernsMargin Compression Risk - dars.gov.et
ISPC Q3 2024 Earnings: Massive EPS Miss Overshadows Slight Stock UptickEPS Surprise History - dars.gov.et
iSpecimen (ISPC) Registration filing Summary - Quartr
iSpecimen (NASDAQ: ISPC) targets $5M best‑efforts equity raise - Stock Titan
iSpecimen Inc (NASDAQ: ISPC) Share Price, ISPC Stock News, ISPC Share Price & Updates - Kalkine
iSpecimen advances digital transformation with Milestone 3 completion - TipRanks
iSpecimen (NASDAQ: ISPC) reaches digital Milestone 3 with $700,000 payment - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com
ISPC Q3 2024 Earnings: Wider-Than-Expected Loss Sparks Surprising Stock SurgeDividend Increase Stocks - dars.gov.et
ISPC Q3 2024 Earnings: Wider-than-Expected Loss Yet Shares SurgeSpecial Dividend Alert - DonanımHaber
iSpecimen Inc. (ISPC) Edges Lower as Key Support Level NearsLow Beta Factor - po-news-eg.net
iSpecimen (NASDAQ: ISPC) files S-1/A for up to $4M equity and pre-funded warrants - Stock Titan
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):